Concepedia

Pauline M. van Helden

PM

Statistics

Publications

13

Citations

450

H-Index

11

Active since

2002

Affiliations

AIMM Therapeutics (Netherlands)(Current)

Sanquin

Amsterdam UMC Location University of Amsterdam

Baxter (Austria)

University Medical Center Utrecht

Pauline M. van Helden is an author at AIMM Therapeutics (Netherlands) specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2002–2020

13

Publications

13

IgG subclasses of anti‐FVIII antibodies during immune tolerance induction in patients with hemophilia A

Pauline M. van Helden, H. Marijke van den Berg, Samantha C. Gouw et al. · British Journal of Haematology · 2008 · 93 citations · Full text

, , +21

CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice

Katharina Nora Steinitz, Pauline M. van Helden, Brigitte Binder et al. · Blood · 2012 · 73 citations · Full text

The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity

Marijn A. Gillissen, Etsuko Yasuda, Greta de Jong et al. · Journal of Immunological Methods · 2016 · 47 citations · Full text

, , +22

Selective Requirement for CD40-CD154 in Drug-Induced Type 1 Versus Type 2 Responses to Trinitrophenyl-Ovalbumin

Stefan Nierkens, Pauline M. van Helden, Marianne Bol et al. · The Journal of Immunology · 2002 · 33 citations · Full text

Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice

Marijn A. Gillissen, Greta de Jong, Martijn Kedde et al. · Blood Advances · 2017 · 31 citations · Full text

, , +17

1–5 of 13